Pasithea Therapeutics
NASDAQ: KTTAVenice, US · Founded 2020 · Delaware corporation · 1 known investors
Founders & leadership
LS
Lawrence SteinmanDirector
TR
Tiago Reis MarquesDirector
IM
Israel Maxx AbramowitzExecutive Officer, Director
CA
Craig AuringerExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$30.4MraisedDec 2021 · 21 investors · BiotechnologyRule 506(b)
▶$30.4MraisedDec 2021 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lawrence SteinmanDirector
- Simon DumesnilDirector
- Stanley M. GlossExecutive Officer
- Emer LeahyDirector
- Tiago Andre Dos Reis MarquesExecutive Officer, Director
- Yassine BendiabdallahExecutive Officer, Director
- Offering amount
- $30.4M
- Amount sold
- $30.4M
- Sales commissions
- $2.7M
- Placement agents
- EF Hutton, division of Benchmark Investments, LLC
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.2MraisedMar 2021 · 30 investors · Other Health CareRule 506(b)
▶$1.2MraisedMar 2021 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lawrence SteinmanDirector
- Tiago Reis MarquesDirector
- Israel Maxx AbramowitzExecutive Officer, Director
- Craig AuringerExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.2M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$250KraisedJan 2021 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedJan 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lawrence SteinmanDirector
- Tiago Reis MarquesDirector
- Israel Maxx AbramowitzExecutive Officer, Director
- Craig AuringerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $250K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.